Russell Frank Company’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Russell Frank Company’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$495K	Buy	11,717 +3,224	+38%	+$164K	﹤0.01%	2460
2015 Q4	$663K	Buy	8,493 +7,625	+878%	+$441K	﹤0.01%	2391
2015 Q3	$35K	Buy	868 +766	+751%	+$40.6K	﹤0.01%	2931
2015 Q2	$6K	Sell	102 -14,827	-99%	-$738K	﹤0.01%	3030
2015 Q1	$695K	Sell	14,929 -5,216	-26%	-$271K	﹤0.01%	2310
2014 Q4	$902K	Sell	20,145 -5,284	-21%	-$222K	﹤0.01%	2190
2014 Q3	$990K	Buy	25,429 +4,103	+19%	+$161K	﹤0.01%	2066
2014 Q2	$858K	Buy	+21,326	New	+$783K	﹤0.01%	2125

Other funds holding ISEE

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JCG

JHL Capital Group Chicago, Illinois $805M AUM 50.84% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Russell Frank Company's ISEE Position: Q1 2016 in Review

Russell Frank Company increased its IVERIC bio, Inc. Common Stock (ISEE) stake by 38% in Q1 2016, buying an estimated $164K and bringing the position to 11,717 shares worth $495K. The position accounts for ﹤0.01% of the portfolio, ranked #2460.

Russell Frank Company first reported a position in ISEE in Q2 2014 and has held it in 8 quarters since. The position peaked at $990K in Q3 2014. 162 funds tracked by Wall St. Rank hold ISEE as of Q1 2016.

Russell Frank Company held 11,717 shares of IVERIC bio, Inc. Common Stock worth $495K as of Q1 2016.
Russell Frank Company bought 3,224 IVERIC bio, Inc. Common Stock shares in Q1 2016, an estimated $164K.
IVERIC bio, Inc. Common Stock made up ﹤0.01% of Russell Frank Company's portfolio in Q1 2016, its #2460 holding.
Russell Frank Company first reported a position in IVERIC bio, Inc. Common Stock in Q2 2014 and has held it in 8 quarters since.
Russell Frank Company's IVERIC bio, Inc. Common Stock position peaked at $990K in Q3 2014.
162 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.